| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,250 | 7,050 | 18:50 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 35,000 | 6 | |||
| 33,000 | 33 | |||
| 11,000 | 500 | |||
| 9,500 | 175 | |||
| 8,550 | 450 | |||
| 7,050 | 1.377 | |||
| 7,000 | 70 | |||
| 6,900 | 70 | |||
| 6,800 | 701 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/88q.htm [/URL] | ||||
| 631 | 6,450 | |||
| 70 | 6,400 | |||
| 70 | 6,300 | |||
| 1.377 | 6,250 | |||
| 70 | 6,200 | |||
| 300 | 4,900 | |||
| 700 | 4,740 | |||
| 1.061 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 4.279 | 0,790 | 3.382 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | 0,000 0,00 % | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09. | 4basebio meldet starken Anstieg der Auftragseingänge bei sinkendem Umsatz | 35 | Investing.com Deutsch | ||
| 28.09. | 4basebio reports 210% rise in H1 sales orders amid revenue decline | 11 | Investing.com | ||
| 28.09. | 4basebio PLC H1 Loss Rises | 6 | RTTNews | ||
| 28.09. | 4BASEBIO PLC: 4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program | 9 | Cision News | ||
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 07.09. | 4basebio Plc - 4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine | 698 | PR Newswire | 4basebio Plc - 4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine
PR Newswire
LONDON, United Kingdom, September 07
4basebio... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 15:46 | Nicht Bayer oder BioNTech: Diese attraktiv bewertete Biotechnologie-Aktie ist jetzt ein klarer Kauf! | FinanzNachrichten.de | © Foto: Sangharsh Lohakare auf Unsplash.Die Aktie von US-Biotechnologiekonzern Regeneron bietet nach einer Korrektur in den vergangenen Wochen eine fundamental attraktive Einstiegsgelegenheit.
Biotechnologie... ► Artikel lesen | |
| 14:06 | Morning Market Movers: WISeSat.Space, Veea, Vaxcyte, Stablecoin Development Corporation See Big Swings | AFX News | BRASILIA (dpa-AFX) - At 7:35 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 17:48 | Idorsia Pharmaceuticals Ltd: Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension | GlobeNewswire (Europe) | Two oral presentations at AHA Hypertension 2026 will highlight the substantial antihypertensive efficacy of aprocitentan in two hypertension populations from the PRECISION study: patients with obesity... ► Artikel lesen | |
| 13:12 | Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold | GlobeNewswire (Europe) | ANN ARBOR, Mich., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced... ► Artikel lesen | |
| 13:48 | Summit Therapeutics Secures $2B Strategic Investment From AstraZeneca | AFX News | LONDON (dpa-AFX) - Summit Therapeutics Inc. (SMMT) on Monday announced the closing of AstraZeneca's (AZN) $2 billion strategic equity investment, which will support accelerated development of... ► Artikel lesen |